AMH to Participate in Nareit’s REITweek 2025 Investor Conference

AMH (NYSE: AMH), a leading large-scale integrated owner, operator and developer of single-family rental homes, today announced that members of the Company's management team will participate in a roundtable discussion duringNareit's REITweek 2025 Investor Conference on Tuesday, June 3, 2025 at 11:00 a.m. Eastern Time. https://mma.prnewswire.com/media/1990748/AMH_Logo.jpg A live audio webcast of the presentation will be […]

SenesTech to Participate in the Lytham Partners Spring 2025 Investor Conference on May 29, 2025

SenesTech, Inc. (NASDAQ: SNES, “SenesTech” or the “Company”), a pioneer in fertility control solutions for managing rodent populations, today announced that it will participate in a webcast fireside chat and host one-on-one meetings with investors at the Lytham Partners Spring 2025 Investor Conference, taking place virtually on Thursday, May 29, 2025. https://mma.prnewswire.com/media/2695354/SenesTech_Logo.jpg Company Webcast The

American Healthcare REIT to Present at Nareit’s REITweek: 2025 Investor Conference

American Healthcare REIT, Inc. (NYSE: AHR) announced today that Chief Executive Officer and President Danny Prosky, Chief Financial Officer Brian S. Peay, Chief Operating Officer Gabe M. Willhite, and Vice President of Investor Relations and Finance Alan Peterson will deliver a company presentation at Nareit's REITweek: 2025 Investor Conference on Wednesday, June 4, 2025, from

China Natural Resources Announces 8-to-1 Share Combination

China Natural Resources, Inc. (NASDAQ: CHNR), a British Virgin Islands (“BVI”) company(the “Company”) today announced that the board of directors of the Company has approved an eight-to-one share combination of issued and outstanding common shares, without par value, of the Company. No shareholders' approval of the share combination is required pursuant to BVI law. The

ONEOK to Participate in Investor Conference

ONEOK, Inc. (NYSE: OKE) will participate in an investor conference this week and in a fireside chat session at 2:30 p.m. Eastern Time (1:30 p.m. Central Time) on Wednesday, May 28. https://mma.prnewswire.com/media/2566222/ONEOK_logo_Logo.jpg The session will be webcast live on ONEOK's website at www.oneok.com. The webcast will also be available for replay. ONEOK's latest investor materials

CMC Announces Third Quarter Fiscal 2025 Conference Call Webcast Details

Commercial Metals Company (NYSE: CMC), in conjunction with its third quarter earnings release for fiscal 2025, invites you to listen to its conference call that will be broadcast live over the Internet on Monday, June 23, 2025, at 11:00 a.m. Eastern Time (10:00 a.m. Central) with Peter Matt, President and Chief Executive Officer, and Paul

Dentsply Sirona Declares Quarterly Cash Dividend

(NASDAQ:XRAY), CHARLOTTE, N.C., May 27, 2025 (GLOBE NEWSWIRE) — DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the “Company”) (Nasdaq: XRAY) announced that its Board of Directors declared a quarterly cash dividend of $0.16 per share of common stock, an indicated annual rate of $0.64 per share. The dividend is payable on July 11, 2025, to holders

Precision Optics to Participate in the Lytham Partners Spring 2025 Investor Conference on May 29, 2025

(NASDAQ:POCI), GARDNER, Mass., May 27, 2025 (GLOBE NEWSWIRE) — Precision Optics Corporation, Inc. (Nasdaq: POCI) (the “Company”), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries, today announced it will participate in a webcast presentation and host one-on-one meetings with investors at the Lytham Partners Spring 2025 Investor Conference,

Anaptys to Announce Updated Data from Phase 2b Trial of Rosnilimab, a PD-1 Depleter and Agonist, for Rheumatoid Arthritis on June 3, 2025

(NASDAQ:ANAB), SAN DIEGO, May 27, 2025 (GLOBE NEWSWIRE) — AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, will host an investor call and live webcast to review updated data from the global Phase 2b RENOIR clinical trial of investigational rosnilimab, a depleter and agonist targeting PD-1+ T cells, for

Kayne Anderson Energy Infrastructure Fund Announces Appointment of New Independent Directors

(NYSE:KYN),(NYSE:PWR),(NYSE:AMRZ),(NYSE:DVN),(NYSE:SRE), HOUSTON, May 27, 2025 (GLOBE NEWSWIRE) — Kayne Anderson Energy Infrastructure Fund, Inc. (the “Company” or “KYN”) announced today the appointments of Holli C. Ladhani and Michael N. Mears as independent directors of the Company, effective immediately. Following the retirements of Anne K. Costin and Albert L. Richey earlier this year, the appointments of

Scroll to Top